WWM
CDNA icon

Wolff Wiese Magana’s CareDx CDNA Stock Holding History

Wolff Wiese Magana’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20
Closed – – 810
2022
Q3 		$0 Buy
+20
New +$429 ﹤0.01% 837

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Wolff Wiese Magana's CDNA Position: Q4 2022 in Review

Wolff Wiese Magana sold out of CareDx (CDNA) in Q4 2022, closing a stake of 20 shares.

Wolff Wiese Magana first reported a position in CDNA in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • Wolff Wiese Magana reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • Wolff Wiese Magana sold 20 CareDx shares in Q4 2022.
  • Wolff Wiese Magana first reported a position in CareDx in Q3 2022 and held it in 1 quarter.
  • Wolff Wiese Magana's CareDx position peaked at $0 in Q3 2022.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Wolff Wiese Magana's 13F filing for Q4 2022, filed 9 Feb 2023.